P1.09-09 Evaluation of a Novel ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in NSCLC Patients by Conde, E., Hernandez, S., Martinez, R., De Castro, J., Collazo-Lorduy, A., Jimenez, B., Muriel, A., Mate, J.L., Morán, T., Aranda, I., Massuti, B., Rojo, F., Domine, M., Sansano, I., Garcia, F., Felip, E., Mancheño, N., Juan, O., Sanz, J., Gonzalez-Larriba, J.L., Atienza-Cuevas, L., Arriola-Arellano, E., Abdulkader, I., Garcia, J., Camacho, C., Rodríguez-Abreu, D., Teixido, C., Reguart, N., Gonzalez-Piñeiro, A., Lazaro-Quintela, M., Lozano, M.D., Gurpide, A., Gomez-Roman, J., Lopez-Brea, M., Pijuan, L., Salido, M., Arriola, E., Company, A., Insa, A., Esteban, I., Saiz, M., Azkona, E., Alvarez, R., Artal, A., Enguita, A.B., Benito, A., Paz-Ares, L., Garrido, P., Lopez-Rios, F.

Get full text

8753 POSTER Experience With CPT-11-Bevacizumab in Patients With Recurrent Malignant Glioma in Puerta del Mar Hospital by Daffos, P. Ramirez, Varela, P. Rosado, Mendoza, S. Estalella, Gutierrez, M.J. Morales, Arellano, E. Arriola, Gomez, M.J, Rueda, A, Contreras, J.A, Canada, J.M. Baena

Get full text